Abbott Capitalizes On Pandemic Testing Boom; Device Sales Stay Almost Flat

 
• By Reed Miller

Abbott reported almost 28% revenue growth in the fourth quarter led by the exploding demand for COVID-19 tests and continued success of its FreeStyle Libre continuous glucose monitor.

Pyramid, cylinder and a sphere in perfect balance
• Source: shutterstock.com

More from In Vitro Diagnostics

More from Diagnostics